Greenwich LifeSciences, Inc.

NASDAQ:GLSI

Biotechnology

Healthcare
$19.79 -3.08%

-$0.74 today

Market cap
$290.48M
Beta
1.38
P/E (TTM)
-15.6
EPS (TTM)
-$1.49
52W Low $7.78High $34.10

Volume 0.23M

Average 0.14M

Balance Sheet

Inspect the capital base behind the business.

Assets

-$6.74M

FY 2025 · Annual

Liabilities

$2.02M

FY 2025 · Annual

+29.3% YoY

Equity

$1.79M

FY 2025 · Annual

-29.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents27.2M13.47M6.99M4.09M(6.74M)
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets00000
Total Current Assets27.2M13.47M6.99M4.09M(6.74M)
Property, Plant & Equipment (Net)00000
Goodwill00000
Intangible Assets12.62K9K5.39K1.78K0
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets12.62K9K5.39K1.78K0
Total Assets27.22M13.48M6.99M4.09M(6.74M)
Account Payables0035.47K1.18M0
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities000382.2K5.55M
Total Current Liabilities385.17K262.91K294.41K1.56M5.82M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities00000
Total Liabilities385.17K262.91K294.41K1.56M2.02M
Common Stock13.15K12.85K12.85K13.15K14.3K
Retained Earnings(33.65M)(41.47M)(50.36M)(66.15M)(87.14M)
Accumulated OCI(0)0000
Other Stockholders Equity00001.79M
Minority Interest00000
Total Equity26.83M13.21M6.7M2.53M1.79M
Total Debt00000
Net Debt(27.2M)(13.47M)(6.99M)(4.09M)6.74M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$10.5M
Total Current Assets$10.5M
Total Assets$10.5M

Analysis

Selected assets total $10.5M for Latest. The largest visible component is Cash & Equivalents at $10.5M, about 100.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
DEFA14ADEFA14A filingOct 26, 2026
DEF 14ADEF 14A filingOct 26, 2026
ARSARS filingOct 26, 2026
10-QQuarterly reportAug 11, 2026
4Statement of changes in beneficial ownershipJul 30, 2026

How much cash does GLSI have?

Greenwich LifeSciences, Inc. (GLSI) reported -$6.74M in cash and equivalents in fiscal 2025.

How much debt does GLSI carry?

Greenwich LifeSciences, Inc. (GLSI) reported $0.00 of total debt, with net debt of $6.74M.